The stock was sold at an average price of $64.18 per share, for a total transaction price of $1.54 million. Ms. Gulmi now owns 118,057 company shares, which are valued at approximately $7.58 million.
AmSurg has a one-year low of $40 and a one-year high of $65.03, according to the report.
More articles on transactions and valuation issues:
Surgery Partners prepares to file IPO
5 things to know about North Carolina’s CON reform bill
Study questions the efficacy of CON programs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.